Alpha 2.0
Login Register
» Articles » PMID: 35118775

Impact of Sacubitril/valsartan on Cardiac Arrest Event Rate. Letter Regarding the Article 'Prospective ARNI Vs. ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After Myocardial Infarction (PARADISE-MI): Design And...

Overview
Journal Eur J Heart Fail
Publisher Wiley
Specialty Cardiology & Vascular Diseases
Date 2022 Feb 4
PMID 35118775
Authors
Ibrahim El-Battrawy
Ibrahim Akin
Affiliations
Soon will be listed here.
Citing Articles

Efficacy of Sarcupyrine/valsartan in the treatment of acute myocardial infarction: a meta-analysis.

Ye J, Zheng W, Zhang M, Zhou B, Fu Y, Mao H Am J Transl Res. 2024; 16(10):5749-5762.

PMID: 39544765 PMC: 11558430. DOI: 10.62347/LXNH6644.

Efficacy and safety of angiotensin receptor-neprilysin inhibition in heart failure patients with end-stage kidney disease on maintenance dialysis: A systematic review and meta-analysis.

Nguyen D, Le T, Truong B, Nguyen H Eur J Heart Fail. 2024; 27(1):72-84.

PMID: 39252524 PMC: 11798635. DOI: 10.1002/ejhf.3454.

Short-term effect of sacubitril/valsartan on endothelial dysfunction and arterial stiffness in patients with chronic heart failure.

Cassano V, Armentaro G, Magurno M, Aiello V, Borrello F, Miceli S Front Pharmacol. 2022; 13:1069828.

PMID: 36545306 PMC: 9760824. DOI: 10.3389/fphar.2022.1069828.

The Effect of Sacubitril/Valsartan Treatment on Cardiac and Renal Functions of a Patient With Cardiorenal Syndrome Type 4 and Stage 5 CKD After More Than Three Years of Follow-Up.

Cheng S, Zhou T, Yu L, Chen Y, Zhang Z, Wang J Front Med (Lausanne). 2022; 9:817833.

PMID: 35360715 PMC: 8962615. DOI: 10.3389/fmed.2022.817833.